Launxp Biomedical Co (ROCO:6876) Scaled Net Operating Assets: 0.39 (As of Dec. 2025)


ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$16.30
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co Scaled Net Operating Assets?

Launxp Biomedical Co ROCO:6876 +0.62% 11 Scaled Net Operating Assets is 0.39 as of Dec. 2025. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Launxp Biomedical Co's operating assets for the quarter that ended in Dec. 2025 was NT$353.00 Mil. Launxp Biomedical Co's operating liabilities for the quarter that ended in Dec. 2025 was NT$131.81 Mil. Launxp Biomedical Co's Total Assets for the quarter that ended in Jun. 2025 was NT$568.23 Mil. Therefore, Launxp Biomedical Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.39.

Launxp Biomedical Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co Scaled Net Operating Assets Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.14 0.14 0.19 0.06 1.79

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.06 0.08 0.08 0.45 0.39

ROCO:6876 vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Launxp Biomedical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Launxp Biomedical Co Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's Scaled Net Operating Assets falls into.


ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Launxp Biomedical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(353.001-131.809)/123.911
=1.79

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=403.034 - 50.033
=353.001

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=151.384 - 13.045 - 6.53
=131.809

Launxp Biomedical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Jun. 2025 )
=(353.001-131.809)/568.229
=0.39

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=403.034 - 50.033
=353.001

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=151.384 - 13.045 - 6.53
=131.809

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.39 mean?
Launxp Biomedical Co (ROCO:6876) has a Scaled Net Operating Assets of 0.39 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Launxp Biomedical Co and its competitors.
Is Launxp Biomedical Co's Scaled Net Operating Assets too high?
Launxp Biomedical Co's current Scaled Net Operating Assets is 0.39. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's Scaled Net Operating Assets compare to VRTX and REGN?
Launxp Biomedical Co's Scaled Net Operating Assets of 0.39 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Launxp Biomedical Co and its competitors. Launxp Biomedical Co's current Scaled Net Operating Assets is 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current Scaled Net Operating Assets of 0.39. The current Scaled Net Operating Assets is 0.39. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current Scaled Net Operating Assets is 0.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.30
Price